Skip to main content
Clinical Trials/NCT02374138
NCT02374138CompletedNot Applicable

Improving Asthma Outcomes Through Stress Management

Stephen J. Teach, MD, MPH2 sites in 1 country217 target enrollmentStarted: May 1, 2015Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
217
Locations
2
Primary Endpoint
Symptom-free Days in the Last 14 Days

Study Overview

Brief Summary

Uncontrolled asthma in at-risk youth responds well to guideline-based therapy when patients remain adherent to their management plans. Adherence to inhaled corticosteroids (ICS), when indicated for persistent or uncontrolled asthma, is a critical component of most asthma management plans, and other self-management practices such as trigger avoidance are similarly related to improved asthma outcomes. Adherence to self-management practices is mediated by multiple factors, including psychosocial stress of parents and their children.

A targeted, culturally appropriate intervention to manage psychosocial stress among the parents of young, African American, and socioeconomically disadvantaged urban children with asthma who are receiving guideline-based care may improve asthma self-management, and therefore asthma outcomes.

Our overall aim is to implement and evaluate a highly collaborative, multi-dimensional, culturally appropriate and community-based asthma intervention to augment existing guideline-based best practice. The intervention will target the parents of at-risk, urban, African American youth, and will employ individualized psychosocial stress management and peer support.

Detailed Description

Uncontrolled asthma in at-risk youth responds well to guideline-based therapy when patients remain adherent to their management plans. Adherence to inhaled corticosteroids (ICS), when indicated for persistent or uncontrolled asthma, is a critical component of most asthma management plans, and other self-management practices such as trigger avoidance are similarly related to improved asthma outcomes. Adherence to self-management practices is mediated by multiple factors, including psychosocial stress of parents and their children.

A targeted, culturally appropriate intervention to manage psychosocial stress among the parents of young, African American, and socioeconomically disadvantaged urban children with asthma who are receiving guideline-based care may improve asthma self-management, and therefore asthma outcomes.

Our overall aim is to implement and evaluate a highly collaborative, multi-dimensional, culturally appropriate and community-based asthma intervention to augment existing guideline-based best practice. The intervention will target the parents of at-risk, urban, African American youth, and will employ individualized psychosocial stress management and peer support.

We will conduct a single blind, prospective randomized controlled trial comparing the IMPACT DC Asthma Clinic's existing intervention of guideline-based clinical care, education, and short-term care coordination (usual care) to usual care plus parental stress management in a cohort of up to 200 parent-child dyads of AA youth aged 4-12 years.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
4 Years to 12 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • We plan to enroll parent-child dyads that meet the following criteria:
  • Inclusion criteria (Parent):
  • self-identify as African-American
  • both the legal guardian and primary asthma caregiver of an eligible child.

Exclusion Criteria

  • unable or unwilling to sign informed consent document
  • exclusionary psychiatric condition, including but not limited to psychosis, based on the screening form at recruitment
  • enrolled in another asthma research study.
  • Inclusion criteria (Child):
  • parent-identified as African-American
  • age 4-12 years inclusive at recruitment
  • physician diagnosis of persistent asthma
  • publicly financed insurance
  • Exclusion criteria (Child):
  • chronic medical condition (other than asthma) including but not limited to diabetes, sickle cell disease, heart disease, lung disease or neurological disorder.
  • In addition, the PI may choose to not include a participant if he does not believe it is in the family's best interest to participate.

Arms & Interventions

Usual Care

Active Comparator

IMPACT DC Asthma Clinic intervention of guideline-based clinical care, education, and short-term care coordination

Intervention: Usual Care (Other)

Intervention

Experimental

Parental stress management in addition to IMPACT DC intervention of guideline-based clinical care, education, and short-term care coordination.

Intervention: Parental stress management (Behavioral)

Outcomes

Primary Outcomes

Symptom-free Days in the Last 14 Days

Time Frame: Repeated Measures at 6 months (3 month data collected to allow for repeated measures)

Symptom-free days are defined as a 24-hour period with no coughing, wheezing, chest tightness, or shortness of breath and no need for rescue medications

Secondary Outcomes

  • Asthma Morbidity - Nighttime Asthma Symptoms(Repeated Measures at 6 and 12 months (3m data collected for repeated measures))
  • Asthma Severity and Control(Repeated Measures at 3, 6, and 12 months)
  • Asthma Medication Adherence(Repeated Measures at 6 and 12 months (3m data collected for repeated measures))
  • Health Care Utilization - Emergency Department Visits for Asthma(12 months after enrollment)
  • Parental Stress(Repeated Measures at 6 and 12 months (3m data collected for repeated measures))
  • Parental Depression(Repeated Measures at 6 and 12 months (3m data collected for repeated measures))
  • Caregiver Smoking Behavior(Repeated Measures at 6 and 12 months)
  • Asthma Exacerbations - Courses of Systemic Steroids(Assessed at 6m and 12m following enrollment)
  • Parental Resilience(Repeated Measures at 6 and 12 months)
  • Exacerbations - Hospital Admissions(Assessed at 6m and 12m after enrollment)
  • Symptom-free Days in the Last 14 Days(Repeated Measures at 12 months (with data also assessed at 3m and 6m))
  • Asthma Morbidity - Daytime Asthma Symptoms, Days of Activity Limitations, and Days of Quick Relief Medicine Use(Repeated measures at 6 and 12 months (3m data collected for repeated measures))
  • Number of Participants With AEs and SAEs(12m follow up period)
  • Economic Outcomes(12m follow-up period)
  • Coping Strategies(Repeated measures at 12m FU (6m data used for repeated measures))
  • Mindfulness(Repeated Measures at 6 and 12 months)
  • Child Anxiety(Repeated Measures at 6 and 12 months (3m data collected for repeated measures))
  • Child Depression(Repeated Measures at 6 and 12 months (3m data collected for repeated measures))
  • Caregiver Quality of Life(Repeated Measures at 6 and 12 months (3m data collected for repeated measures))

Investigators

Sponsor
Stephen J. Teach, MD, MPH
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Stephen J. Teach, MD, MPH

Chair, Pediatrics

Children's National Research Institute

Study Sites (2)

Loading locations...

Similar Trials

Breathe With Ease: A Unique Approach to... | Clinical Trial